Gujarat Kidney and Super Speciality Quarterly Results
Gujarat Kidney and Super Speciality quarterly results. In Mar 2026, Gujarat Kidney and Super Speciality (GKSL) reported revenue ₹31 Cr and net profit ₹5 Cr — revenue +210.0% YoY. For annual financials, live price and key ratios, visit Gujarat Kidney and Super Speci screener.
GKSL Quarterly Results — Revenue, Profit & EPS Highlights
Gujarat Kidney and Super Speciality latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review Gujarat Kidney and Super Speci price earnings to evaluate earnings-based valuation against sector peers.
- Revenue of ₹31 Cr in Mar 2026 (-11.4% vs Jun 2026, +210.0% vs Mar 2025)
- Net Profit of ₹5 Cr in Mar 2026 (+0.0% vs Jun 2026, +400.0% vs Mar 2025)
- EBITDA of ₹7 Cr in Mar 2026 (-22.2% vs Jun 2026)
- Operating Margin of 21.0% in Mar 2026 (-3.0pp vs Jun 2026)
- Earnings Per Share of ₹0.81 in Mar 2026 (+22.7% vs Jun 2026)
Gujarat Kidney and Super Speciality Quarterly Results — Revenue, EBITDA, Net Profit & EPS
GKSL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Jun 2026 | Sept 2025 | Mar 2025 | Jun 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 31 | 35 | 13 | 10 | 15 | -11.4% | 210.0% |
| Net Profit (₹ Cr) | 5 | 5 | 3 | 1 | 5 | - | - |
| EBITDA (₹ Cr) | 7 | 9 | 5 | 3 | 9 | - | - |
| EPS (₹) | 0.81 | 0.66 | 0.47 | 0.25 | 0.85 | - | - |
| Operating Margin (%) | 21.0% | 24.0% | 40.0% | 27.0% | 57.0% | - | - |
GKSL Share Price Trend — 1-Year Movement Across Quarterly Results
Gujarat Kidney and Super Speciality 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check GKSL market cap trends to track the company's total market size over time.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
GKSL vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap
Gujarat Kidney and Super Speciality latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Apollo Hospitals
Mar 2026 |
₹116,947.25 Cr | 7985.0 | 6,660 | 551 | -6.3% | - | 8.3% | 216.9 |
|
Max Healthcare Inst…
Mar 2026 |
₹87,841.25 Cr | 917.0 | 2,191 | 342 | -9.0% | - | 15.6% | 260.5 |
|
Fortis Healthcare
Mar 2026 |
₹57,663.70 Cr | 763.8 | 2,375 | 271 | -7.7% | - | 11.4% | 217.0 |
|
Aster DM Healthcare
Mar 2026 |
₹42,146.56 Cr | 691.5 | 1,219 | 154 | -0.6% | +18.1% | 12.6% | 254.2 |
|
Global Health
Mar 2026 |
₹38,047.48 Cr | 1332.6 | 1,196 | 142 | -9.8% | - | 11.9% | 248.6 |
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores